Deep Track Capital, LP
Q4 2024 13F Holdings
- Locationgreenwich, CT
- Num holdings
63
- Value ($000)
$2,681,037
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001856083
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
DVAX DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | $227.20M | 9 % | 17,791,486 | ||
GH GUARDANT HEALTH INC | COM | 40131M109 | $196.12M | 7 % | 6,419,566 | ||
ITCI INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | $167.04M | 6 % | 2,000,000 | ||
IMVT IMMUNOVANT INC | COM | 45258J102 | $148.62M | 6 % | 6,000,000 | ||
APLS APELLIS PHARMACEUTICALS INC | COM | 03753U106 | $136.41M | 5 % | 4,274,921 | ||
SWTX SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | $125.04M | 5 % | 3,460,756 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $117.60M | 4 % | 2,500,000 | ||
OCUL OCULAR THERAPEUTIX INC | COM | 67576A100 | $109.62M | 4 % | 12,836,282 | ||
VRDN VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | $86.70M | 3 % | 4,522,741 | ||
PLRX PLIANT THERAPEUTICS INC | COM | 729139105 | $78.65M | 3 % | 5,972,257 |
Rows Per Page
1 - 10 of 6310
- 10
- 50
- 100